Table:
begin	end	state
1	40	cytoplasmic
41	60	transmembrane
61	65	non-cytoplasmic
66	88	transmembrane
89	99	cytoplasmic
100	120	transmembrane
121	125	non-cytoplasmic
126	148	transmembrane
149	164	cytoplasmic
165	189	transmembrane
190	200	non-cytoplasmic
201	220	transmembrane
221	257	cytoplasmic
258	279	transmembrane
280	294	non-cytoplasmic
295	312	transmembrane
313	323	cytoplasmic
324	342	transmembrane
343	347	non-cytoplasmic
348	372	transmembrane
373	384	cytoplasmic
385	409	transmembrane
410	416	non-cytoplasmic
417	436	transmembrane
437	447	cytoplasmic

Input:
>WP_090448576.1 NCBI__GCF_900100495.1:WP_090448576.1
MSASSESLAYGRAPSRSTSSERSTLRRAATASFIGNFVEWFDYAAYGYLAAVIAVVFFPA
TDKTSGLLAAFAVFAISFIVRPIGGIVWGHIGDRYGRRNALSLSILIMSGATFCIAFLPT
YAQVGLWAPLLLLLIRLVQGFSASGEYAGASAFLAEYAPDNRRGFFTSLVPASTAAGLLF
GSLFAAMLYSQLDGEQLHSWGWRLPFLLAAPMGLIGRYIRLHLQDTPKFREMEQALEKKE
GEHKVPIRELFGAQRKRVLVAIGVTCLNAVAFYLILSYMPTYLATEMGMNETDSFLASTV
SLATYIGFIFLMGKLSDRFGRKTMLILASLLFLGLTLPLFGMLEGRSFAFILLIQIAFGL
MLAMNDGTLPCFLAEIFPTRVRYSGFAFSFNTANALFGGTAPFIATWLISQSGDKMAPAW
MLMGAAAVALVAMLMITETAHKALADD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server